[Featured Stock] Selvas Healthcare Advances AI Medical Diagnosis with Elon Musk... US AI Diagnostic Business Spotlighted Upward

Selvas Healthcare is showing strong performance. This is interpreted as being influenced by expectations for CEO Elon Musk's artificial intelligence (AI) medical diagnosis business. Selvas Healthcare is jointly pursuing a business with a US AI cardiac diagnosis company.

As of 1:28 PM on the 19th, Selvas Healthcare is trading at 4,375 KRW, up 17.29% compared to the previous day.

According to foreign media on the 18th (local time), CEO Musk posted on X that the capabilities of AI are likely to soon evolve to the level of professionals such as doctors and lawyers.

Musk is reportedly actively pursuing a plan to share individuals' medical information in preparation for such a situation.

According to foreign media, Musk-owned social media platform X has recently collected personal medical information from X users over the past few weeks, including X-ray images, magnetic resonance imaging (MRI) data, and computed tomography (CT) scans.

Earlier, on the 29th of last month, Musk posted on X that "if personal medical information is provided to Grok, Grok can carry out analysis work." Grok is a generative AI model developed by xAI, an AI startup founded by Musk.

Meanwhile, UltraSite, in which Selvas Healthcare has invested and is jointly promoting AI remote medical services, has received approval from the US FDA (Food and Drug Administration) for its 'AI Cardiac Ultrasound Solution.' UltraSite's 'AI Cardiac Ultrasound' combines portable ultrasound devices with AI imaging intelligence technology to provide real-time cardiac ultrasound guidance.

This content was produced with the assistance of AI translation services.